Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) Study | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) Study	COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, influenza, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia	Active, not recruiting	Phase 4	2026-09-11		NCT07287137

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Centers for Disease Control and Prevention	84
Food and Drug Administration (FDA)	31
Henry M. Jackson Foundation for the Advancement of Military Medicine	35

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Walter Reed National Military Medical Center	Bethesda	United States	18